peptide-service
Paid brief first for peptide projects.
Best for
Teams that need a clean peptide entry point.
Typical outputs
- Scope call
- Quote
- Next step
Three primary lanes. Three specialty services. One flagship engine. One strategic pipeline. Two lanes in the waitlist queue. Every request returns a route preview, an owner, and a clear next step. If the fit is weak, we say so quickly and keep the handoff clean.
The default entry points. Each is a clean route from inquiry to a decision-ready handoff.
Paid brief first for peptide projects.
Best for
Teams that need a clean peptide entry point.
Typical outputs
Biostatistics for decision-ready outputs.
Best for
Teams that need clearer evidence, faster.
Typical outputs
Discovery support for scope and partnership talks.
Best for
Partners exploring a new research direction.
Typical outputs
Use these when the request is more technical or the deliverable needs a defensible methodology.
Molecular reasoning layer — FPembed fingerprinting + ARP v24 decision-scored candidates.
Best for
Teams that need decision-scored molecules, not a similarity list.
Typical outputs
TrueSkill-ranked preprint tournament. PRISMA-RAISE compliant briefs — qualitative reasoning layer on top of automated extraction.
Best for
Longevity / omics / fibrosis teams that want ranked candidates, not a reading list.
Typical outputs
Audit-grade transcriptomics pipelines with RO-Crate provenance and LLM-validated gates.
Best for
Teams that need a defensible, reproducible multi-platform omics workflow.
Typical outputs
Keep the entry point small, then expand only when the scope, owner, and next action are clear.
See the full pricing breakdownSample Brief
₩0.3M ~ ₩1M
Preview / scope check
Paid Brief
₩2M ~ ₩8M
Decision-ready, PRISMA-RAISE compliant
Project
₩8M ~ ₩30M+
Scoped analysis + execution
Retainer
₩3M ~ ₩15M+/mo
Monthly research / ops support
Brown Biotech's flagship engine. Continuous reasoning over public life-science data, with human approval gates. Every other lane runs on top of it.
The System of Intelligence behind every Brown Biotech lane. Continuous reasoning layer over public life-science data, with human approval gates.
Best for
Teams that want to understand — or build on — the reasoning engine.
Typical outputs
Single-file biotech landing pages — generated, downloadable, ready to email. Outreach, conference booths, sample-brief previews.
Best for
BB operators and partners who need a one-pager artifact in under a minute.
Typical outputs
Brown Biotech can package the business pipeline itself as a higher-tier offering for teams that want a reusable workflow with review.
A company-owned pipeline for biotech ops and decision-ready briefs.
Best for
Teams that want a reusable workflow with review.
Typical outputs
Two lanes in the queue — including ondining's Gwangju social-dining pilot. Join the waitlist to be first when they ship.
AI research agent tournament for biotech hypothesis generation.
Best for
Teams that want structured competitive AI research with ranking.
Typical outputs
Social dining for adults 40–60. Curated tables of 5–6 guests, trained hosts, designed with a medical advisor.
Best for
Adults who want a real evening conversation, and municipal / insurer / corporate wellness partners.
Typical outputs
Define the problem and the outcome.
Assign the lane and first milestone.
Send one clear next step.
Keep the proof visible, keep the outputs reusable, and route serious interest into a clear next step.
Turn the work into decision-ready evidence: scoped memo, citations, and a reusable summary.
Keep selected outputs public so the market can see what Brown Biotech actually ships.
Use talks, reading notes, and partner updates to keep the ecosystem warm and visible.
Route serious inbound interest into a brief, owner, and next action instead of a loose chat.
Brown Biotech should be able to retrieve not just text, but PDFs, screenshots, figures, slides, and audio notes so the brief stays decision-ready.
Decision-ready summaries and scoped requests.
Screenshots, figures, slides, and chart captures.
Meeting clips and spoken context tied back to the brief.
Reusable language only after human review.
Roche's PathAI deal is a good reminder that diagnostics value comes from workflow integration, not just model quality.
Roche × PathAI (2026-05-07)
Diagnostics value now sits in the workflow, not only the model.
Brown Biotech should sell decision-ready routing and review loops, not generic AI.
Nemotron persona team
Small, specialized roles can improve throughput when the handoff is crisp.
The router should output route, owner, approval gate, and next action every time.
A short problem statement and the outcome you want.
We aim to respond within 24 hours.
Yes. We adapt to scope and budget.
Send a short note and we'll route it.